NASDAQ: MOVEMovano Inc Stock
$0.80-0.05 (-5.88%)
Updated Apr 22, 2025
MOVE Price
$0.80
Fair Value Price
$0.28
Market Cap
$5.63M
52 Week Low
$0.71
52 Week High
$8.85
P/E
-0.2x
P/B
0.77x
P/S
32.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.01M
Earnings
-$23.73M
Gross Margin
-196.8%
Operating Margin
-2,342.25%
Profit Margin
-2,342.3%
Debt to Equity
0.54
Operating Cash Flow
-$23M
Beta
0.82
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MOVE Overview
Movano Incorporated offers a radiofrequency technology platform that enables the creation of sensors small enough to fit into wearable devices. The company's Movano Ring measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is planning to add non-invasive continuous glucose monitoring and cuffless blood pressure monitoring to its platform. Movano was incorporated in 2018 and is based in Pleasanton, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MOVE's potential to beat the market
- MOVE doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
B
MOVE
RankedUnranked of 103
RankedUnranked of 103
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.49 | A | |
| $22.99 | A | |
| $13.80 | A |
Be the first to know about important MOVE news, forecast changes, insider trades & much more!
MOVE News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MOVE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MOVE ($0.80) is overvalued by 181.21% relative to our estimate of its Fair Value price of $0.28 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MOVE ($0.80) is not significantly undervalued (181.21%) relative to our estimate of its Fair Value price of $0.28 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MOVE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MOVE due diligence checks available for Premium users.
Valuation
MOVE fair value
Fair Value of MOVE stock based on Discounted Cash Flow (DCF)
Price
$0.80
Fair Value
$0.28
Overvalued by
181.21%
MOVE ($0.80) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MOVE ($0.80) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MOVE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MOVE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.2x
Industry
41.11x
Market
28.14x
MOVE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.77x
Industry
3.8x
MOVE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MOVE's financial health
Profit margin
Revenue
$111.0k
Net Income
-$4.6M
Profit Margin
-4,158.6%
MOVE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MOVE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$11.3M
Liabilities
$4.0M
Debt to equity
0.54
MOVE's short-term assets ($10.39M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MOVE's short-term assets ($10.39M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MOVE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MOVE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.6M
Investing
-$5.0k
Financing
$1.2M
MOVE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MOVE vs Medical Device Stocks
Movano Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.